Microcarriers Market Get Facts About Business Strategies 2022 to 2030: Grand View Research Inc.

 

Microcarriers Market Growth & Trends

The global microcarriers market size is estimated to reach USD 3.2 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 11.6% from 2022 to 2030. The growth of the market is driven by the rising demand of cell-cultured products, the growing burden of diseases worldwide, constant investments for intensive R&D activities to identify and develop new treatments for rare disorders, and the continuous developments in technologies employed in advanced research such as cell-biology.4

Amidst the COVID-19 pandemic, the market witnessed a positive growth. The continuous strive of scientist and researchers to find and develop vaccines for the SARS-CoV2 virus resulted in scaling up of R&D efforts by both healthcare companies and academic institutes. The increased research activities, huge funding, and growing demand of therapeutic products resulted in the growth of the market. Moreover, development of viral vectors based vaccines requires efficient production of viruses which is possible using microcarriers cell-culture. For instance, scientists from University of Copenhagen demonstrated in their research article published in June 2021 that SARS-CoV2 virus was efficiently produced in Vero cells in a single-use bioreactors packed with carrier beads. Findings like these have boosted the COVID-19 vaccine production further propelling market growth.

Moreover, the marketspace is rapidly expanding owing to the high usage of microcarriers as matrix for adherent cell manufacturing and these small spherical beads are used across all scales of commercial production. The increasing demand of innovative therapeutic options such as cell and gene therapy, viral vaccines, and monoclonal antibodies for treatment of malignant and rare diseases has resulted in increase in the biopharmaceutical production capacities. For example, Pfizer Inc., announced in December 2021 that it has invested USD 68.5 million and opened a new facility in North Carolina, USA. With the expansion the company is focused on enhancing its gene therapy capabilities and clinically develops its portfolio for hemophilia A and B, DMD (Duchenne muscular dystrophy), ALS (amyotrophic lateral sclerosis) and many more neurologic, endocrine as well as metabolic diseases. Such increased investments for development of biopharmaceuticals and regenerative medicines are expected to propel the market growth.

Furthermore, cell-biology based research involves exhaustive R&D for developing new therapies. But these efforts require investments for cell lines, media, equipment and other related products for microcarriers culture and thus requires huge influx of money. Institutes and emerging players with budget constraints will limit the cell based research for therapeutics development. Hence, it will decrease the adoption of cell-culture products and restrain the growth. However, government initiatives for novel drug production and collaboration & partnerships with key players can offer investment relief and enhance the market growth.

Request a free sample copy or view report summary: Microcarriers Market Report

Microcarriers Market Report Highlights

• By consumables, the microcarriers beads segment held the largest revenue share in 2021. Presence of key players offering the products along with their continuous usage during bio-manufacturing process drives market growth

• By application, the biopharmaceutical production segment dominated the market in 2021. Increased demand for vaccine during the COVID-19 pandemic and continuous regulatory support for therapeutics boosts the usage of microcarriers during bio-manufacturing, leading to highest segment share

• By end-user, the pharmaceutical and biotechnology companies are the highest revenue generators in microcarriers market in 2021. New drug development programs, intensive R&D pipeline, growing investments for therapeutic products contributes to the revenue generation

• North America region captured the largest share in 2021 for microcarriers market. The major factors for the regional dominance are prevalence of diseases, presence of key market players, high usage of cell based products, and supportive government initiatives

• Asia Pacific region will witness the fastest growth in the microcarriers market during the forecast, due to rising R&D activities, increased domestic demand of biologics and growing economies

Microcarriers Market Segmentation

Access Press Release@ https://www.grandviewresearch.com/press-release/global-microcarriers-market

Grand View Research has segmented the global microcarriers market based on consumables, application, end-user, and region:

Microcarriers Consumables Outlook (Revenue, USD Million, 2018 - 2030)

• Media & Reagents

• Microcarrier Beads

• Collagen Coated Beads

• Cationic Beads

• Protein Coated Beads

• Untreated Beads

• Others

Microcarriers Application Outlook (Revenue, USD Million, 2018 - 2030)

• Biopharmaceutical Production

• Vaccine Production

• Therapeutic Production

• Regenerative Medicine

Microcarriers End-user Outlook (Revenue, USD Million, 2018 - 2030)

• Pharmaceutical & Biotechnology Companies

• Contract Research Organizations & Contract Manufacturing Organizations

• Academic & Research Institutes

Microcarriers Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

  • U.S.

  • Canada

• Europe

  • U.K.

  • Germany

  • France

  • Italy

  • Spain

• Asia Pacific

  • Japan

  • China

  • India

  • South Korea

  • Australia

• Latin America

  • Brazil

  • Mexico

• Middle East & Africa

  • South Africa

  • Saudi Arabia

  • UAE

List of Key Players of Microcarriers Market

• Thermo Fisher Scientific, Inc.

• Merck KGaA

• Danaher Corporation

• Sartorius AG

• Corning Incorporated

• Eppendorf SE

• Bio-Rad Laboratories, Inc.

• HiMedia Laboratories Pvt. Ltd.

• denovoMATRIX GmbH

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Battery Swapping Charging Infrastructure Market Outlook Growth Emerging Factors On Geography, Technological Advancements And Mounting Demand Forecast To 2030

 

Battery Swapping Charging Infrastructure Market Growth & Trends

The global battery swapping charging infrastructure market size is expected to reach USD 811.5 million by 2030, expanding at a CAGR of 20.2% from 2022 to 2030, according to a new report by Grand View Research, Inc. Battery swapping charging infrastructure, also known as battery-as-a-services, eliminates the maintenance and service cost required, reduces the upfront cost of an Electric Vehicle(EV) considerably, cuts down CO2 emissions, and minimizes EV battery wastage. Owing to these advantages of the battery-swapping charging infrastructure, the industry is expected to grow significantly over the forecast period.

Through the battery-swapping charging infrastructure, consumers can borrow batteries as a stand-alone component from automobiles. The upgradation and recharging of batteries provided by the market conquer the shortcomings of plug-in EV chargers, including charging time and range anxiety. It provides charged batteries within a few minutes, comparable to traditional gas stations, thereby reducing the charging time. It provides longevity for long journeys by reducing users' range anxiety by providing them instant battery swapping at multiple locations. These factors are contributing to the growth of the market.

The demand for battery-swapping charging infrastructure is closely related to and dependent on the demand for electric vehicles. Governments across the world are engaging in strategic initiatives to promote electric vehicles. For instance, a multi-government policy group called the Electric Vehicles Initiative (EVI) was established to hasten the introduction and adoption of electric vehicles. EVI was established as part of the Clean Energy Ministerial (CEM), a high-level conference for the world's leading economies' energy ministers. Multiple countries, including the U.S., Canada, France, Germany, U.K., Netherlands, India, and Japan, have participated in EVI.

Such government initiatives are driving the adoption of electric vehicles which bodes well for the market. The COVID-19 pandemic had an adverse effect on global car sales. According to a report published by the International Energy Agency, global car sales witnessed an unprecedented drop in sales. However, global electric car sales grew by 40% from 2019 to 2020. The pandemic highlighted the need to adopt more environmentally cautious practices, driving the adoption of EVs. With the increasing demand for EVs, demand for public charging infrastructure also increased, driving the growth of the global market.

Request a free sample copy or view report summary: Battery Swapping Charging Infrastructure Market Report

Battery Swapping Charging Infrastructure Market Report Highlights

• The two-wheelers segment is expected to witness significant growth over the forecast period. Battery-swapping charging infrastructure provides a cost-efficient alternative. Traditional battery charging requires high upfront expenditure, while battery-as-a-service reduces the upfront cost

• Moreover, the time-saving capability and lack of park and charge facilities in tier-I and tier-II cities are driving the installation of battery-swapping stops for two-wheelers, driving the segment’s growth

• The subscription segment is expected to register the fastest CAGR over the forecast period. A subscription allows EV users to rent and swap batteries under a subscription pricing model

• The subscription pricing model enables users to pay monthly/quarterly/yearly for their batteries and removes the hassle of payment every time they want to swap their batteries

• The convenience of subscription battery-swapping charging services is expected to drive the segment’s growth over the forecast period.

• Europe is anticipated to register significant growth over the forecast period. Batteries form a strategic part of Europe’s digital and clean transition, and they are a critical enabling technology that plays a crucial role in the automotive sector’s competitiveness

• Key players in Europe are continuously innovating new battery and charging infrastructures, harnessing the growth of the regional market

Access Press Release@ https://www.grandviewresearch.com/press-release/global-battery-swapping-charging-infrastructure-market

Battery Swapping Charging Infrastructure Market Segmentation

Grand View Research has segmented the global battery-swapping charging infrastructure market on the basis of vehicle type, service type, and region:

Battery Swapping Charging Infrastructure Vehicle Type Outlook (Revenue, USD Million, 2017 - 2030)

• Two-Wheeler

• Three-Wheeler

• Passenger Vehicle

• Commercial Vehicle

Battery Swapping Charging Infrastructure Service Type Outlook (Revenue, USD Million, 2017 - 2030)

• Pay-per-use

• Subscription

Battery Swapping Charging Infrastructure Regional Outlook (Revenue, USD Million, 2017 - 2030)

• North America

  • U.S.

  • Canada

• Europe

  • U.K.

  • Germany

  • France

  • Italy

  • Spain

  • The Netherlands

• Asia Pacific

  • China

  • India

  • Japan

  • Australia

  • South Korea

• Latin America

  • Brazil

  • Mexico

• Middle East & Africa

List of Key Players in the Battery Swapping Charging Infrastructure Market

• NIO Inc.

• Gogoro Inc.

• Leo Motors Inc.

• Tesla Inc.

• SUN Mobility Pvt. Ltd.

• BYD Co. Ltd.

• BattSwap Inc.

• Kwang Yang Motor Co. Ltd. (KYMCO)

• Panasonic Corp.

• Lithion Power Pvt. Ltd.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

U.S. Biopharmaceutical Third-party Logistics Market Report by Opportunity, Demand, Recent Trends, Major Driving Factors and Business Growth Strategies

 

U.S. Biopharmaceutical Third-party Logistics Market Growth & Trends

The U.S. biopharmaceutical third-party logistics market size is expected to reach USD 87.2 billion by 2030, expanding at a CAGR of 7.3% over the forecast period, according to a new report by Grand View Research, Inc. Increasing demand for novel biologics and the need to manage those is boosting the market growth. Besides, rising demand for temperature-controlled logistic services to transport biologics in various regions and growing distribution networks of biopharmaceutical companies to improve their sales are factors driving the growth.

The COVID-19 pandemic has had a major impact on global logistics to some extent due to diminished air freight capacity and reduced workforce at warehouses and airports. The decisions of local authorities to shut down the logistic infrastructure, enforce movement restrictions, or put in place additional requirements to suppress transmission of the virus have also impacted the logistic services. This has significantly hindered many supply operations.

The future seems lucrative for the biopharmaceutical third-party logistics industry in the U.S. with the retraction of government regulations related to transportation and shelter-in-place mandates. A sudden surge in the demand for cold chain logistics was observed during the pandemic. Growth in the manufacture and distribution of the COVID-19 vaccine is expected throughout 2021. For instance, in March 2021, FedEx Express started shipping COVID-19 vaccines for McKesson Corp. to centers all across the U.S. The company has already shipped millions of COVID-19 vaccines since mid-December 2020.

Request a free sample copy or view report summary: U.S. Biopharmaceutical Third-party Logistics Market Report

U.S. Biopharmaceutical Third-party Logistics Market Highlights

• Non-cold chain logistics held the largest market share of 80.2% owing to the sales of a large number of drugs that do not require any temperature control

• The cold chain logistics segment is projected to witness the fastest CAGR of 10.1% over the forecast period owing to the demand for biologics, such as cellular therapies, vaccines, and test kits

• The increasing demand for the COVID-19 vaccine is a major contributor to the market growth. Furthermore, the rising trend of outsourcing logistics services is also fueling the growth

• Warehousing and storage held the largest market share of 43.4% share due to the growing demand for storage

• Specialty drugs dominated the market with the largest share of 39.2% in 2021 due to substantial growth in specialty pharma

Access Press Release@ https://www.grandviewresearch.com/press-release/us-biopharmaceutical-3pl-market-analysis

U.S. Biopharmaceutical Third-party Logistics Market Segmentation

Grand View Research has segmented the U.S. biopharmaceutical third-party logistics market based on supply chain, service, product type, and region:

U.S. Biopharmaceutical Third-party Logistics Supply Chain Outlook (Revenue, USD Billion, 2018 - 2030)

• Cold Chain

• Non-cold Chain

U.S. Biopharmaceutical Third-party Logistics Service Type Outlook (Revenue, USD Billion, 2018 - 2030)

• Transportation

• Air Freight

• Sea Freight

• Overland transportation

• Warehousing and storage

• Others

U.S. Biopharmaceutical Third-party Logistics Product Type Outlook (Revenue, USD Billion, 2018 - 2030)

• Specialty Drugs

• Generics

• Plasma Derived Products

• Others

List of Key Players in the U.S. Biopharmaceutical Third-party Logistics Market

• FedEx.

• DHL International GmbH

• SF Express

• United Parcel Service of America, Inc.

• AmerisourceBergen Corporation

• DB Schenker

• KUEHNE + NAGEL

• Kerry Logistics Network Limited

• Agility

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Social Networking App Market Expected to Deliver Dynamic Progression By 2030

 

Social Networking App Market Growth & Trends

The global social networking app market is expected to reach USD 267.7 billion by 2030, growing at a CAGR of 23.6% from 2022 to 2030, according to the new report by Grand View Research, Inc. The market growth is attributable to the growing demand for digital marketing services across the globe. Rapidly growing demand for inbound marketing strategies in emerging economies such as China and India is bolstering business growth.

Additionally, the digital revolution across the world is supplementing market growth. Moreover, the surge in the adoption of live streaming-based content apps in North America is propelling market growth. According to Pew Research Center, 68% of U.S. users are accessing Facebook through their mobiles. Rising demand for paid advertising services in the U.K. is anticipated to boost market growth.

Social media is an excessive catalyst to drive the website of personal business. Key players are focusing to provide text-to-speech features for social networking apps. The prime key players are offering multiple language support with an advanced user interface. Multiple companies are providing biometric traits to improve security concerns. Low-latency modes with near-field communication are propelling the market growth.

Apple iOS Store segment will register the highest growth in the forecast period. This can be attributed to the growing demand for virtual social platforms from the consumers of the U.S. and U.K. Additional security concerns and real-time threat notifications features are refueling the business growth. Easy video management, portraits with studio light, and automatic updates are reflecting the significant market growth during the forecast period.

The smartphone segment will register the highest growth in the forecast period, which can be attributed to the growing use of smartphones across the globe. The most popular mobile device worldwide is a smartphone that can run apps and connect to the internet. Social networking apps like Instagram, Facebook, Snapchat, and WhatsApp, among others, are popularly used on smartphones. As internet access and smartphone use expand worldwide, which in turn is boosting the social networking app market growth.

Asia Pacific made the largest contribution to the global social networking app with over 45.3% share in 2021 due to the rising demand for high-quality snap filters from the consumer the China and India. The rising trend in China to adopt hyperlapse integrations is propelling market growth. The market share of India is driven by the rising demand for voice navigation-based social networking apps.

Request a free sample copy or view the report summary: Social Networking App Market Report

Social Networking App Market Report Highlights

• The google play store segment accounted for the highest market share of 53.8% in 2021. The growth can be attributed to the increasing number of social networking apps available on the Google Play store.

• The smartphone segment accounted for the highest market share of 57.1% in 2021. The segment's growth can be attributed to the growing penetration of smartphones globally. As most of the social networking apps are supported by smartphones with internet access in turn boosts the market growth.

• The advertising segment accounted for the highest market share of 64.4%in 2021. Companies generate most of their revenue from advertising. Further, advertising on social media apps will help the users in building the brand, improve the conversion rates, and reach new customers among others.

• The Asia Pacific regional market is anticipated to hold the largest market share of more than 45% in 2021. The regional growth can be attributed to the growing demand for AI-powered social networking apps for business networking.

• Europe is projected to witness a CAGR of 28.7% from 2022 to 2030. Soaring demand for machine learning-based chat services in the U.K. is estimated to escalate the market growth over the forecast period.

• Prominent players in the market include Reddit, Meta, Twitter, Meet Up, Tapebook, Tumblr, Viber, Whisper, Line, and Yubo.

Access Press Release@ https://www.grandviewresearch.com/press-release/global-social-networking-app-market

Social Networking App Market Segmentation

Grand View Research has segmented the global social networking app market report based on marketplace type, device type, and region:

Social Networking App place Type Outlook (Revenue, USD Billion, 2017 - 2030)

• Google Play Store

• Apple IOS Store

• Microsoft Store

• Others

Social Networking App Device Type Outlook (Revenue, USD Billion, 2017 - 2030)

• Smartphones

• Others

Social Networking App Revenue Source Outlook (Revenue, USD Million, 2017 - 2030)

• Advertising

• In-App Purchase

• Paid App

Social Networking App Regional Outlook (Revenue, USD Million, 2017 - 2030)

• North America

  • U.S.

  • Canada

• Europe

  • U.K.

  • Germany

  • France

• Asia Pacific

  • China

  • India

  • Japan

• Central & South America

  • Brazil

  • Argentina

• Middle East & Africa

  • Saudi Arabia

  • South Africa

List of Key Players in Social Networking App Market

• Reddit

• Meta

• Twitter

• Meet Up

• Tapebook

• Tumblr

• Viber

• Whisper

• Line

• Yubo

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Enterprise Software Market Trends Regulations And Competitive Landscape Outlook to 2030

 

Enterprise Software Market Growth & Trends

The global enterprise software market size is expected to reach USD 517.26 billion by 2030, expanding at a CAGR of 11.5% from 2022 to 2030, according to a new study conducted by Grand View Research, Inc. The market growth can be attributed to increasing focus of various end-use organizations on digitalizing their business operations, high demand for data-driven decision-making tools, and increasing adoption of cloud computing and data analytics technologies. With enterprise software, organizations are automating various daily tedious tasks, improving their marketing and sales divisions to increase client conversion rates, and modifying business processes to meet evolving market needs. Due to this, demand for enterprise software is expected to increase notably in the forecast period.

The growing number of e-commerce companies and various companies’ preference for enhancing their digital channel interfaces to improve the consumer experience are expected to drive the market in the retail sector. The industry players are strengthening their retail technology solution portfolio to bring innovations in retail-specific enterprise software. For instance, in August 2020, enterprise software provider, Aptean, acquired the product lifecycle management division of retail technology solution company, Aptos. This acquisition will help Aptean expand its cloud-based enterprise software offerings for fashion, luxury, and other retail industries. Moreover, in April 2022, Software AG acquired software services provider, StreamSets for an undisclosed amount. The acquisition will enable Software AG to manage its clients’ data transfer between cloud data platforms, on-premise applications, and other legacy data stores.

Growing demand for enterprise software is encouraging startups to enter this potential industry. The startups are focusing on offering enterprise software at reasonable costs and raising funds to improve their global networks and consumer base. For instance, in March 2022, Locofy.ai, an enterprise software company, raised USD 3 million in a funding round organized by various investing firms such as Boldcap, Golden Gate Ventures, Accel, and January Capital. The company will utilize this funding to expand its software development team and R&D capabilities. Moreover, in July 2022, ElevateHQ, a Business-to-Business (B2B) software provider, raised USD 1.1 million in a funding round of a financial company, Leo Capital. Such an initiative by startups will create a positive outlook for the market in the forecast period.

Request a free sample copy or view report summary: Enterprise Software Market Report

Enterprise Software Market Report Highlights

• The enterprise resource planning software segment is anticipated to expand at a CAGR of 10.7% from 2022 to 2030. Increasing supportive initiatives by the government for digital technologies and the high usage of ERP tools for streamlining the business processes for effective resource utilization is expected to fuel the segment growth from 2022 to 2030

• The cloud deployment segment is expected to register a CAGR of 13.6% from 2022 to 2030 owing to advancements in cloud technologies and reasonable subscription plans introduced by market players. The cloud-based enterprise software offers better working flexibility, a creative user interface, and low operating costs, supporting the market trend

• The small and medium enterprise (SMEs) segment is expected to expand at a CAGR of 13.2% from 2022 to 2030. SMEs are notably adopting enterprise software to reduce their maintenance and inventory costs and improve their workflow capability for better internal collaborations

• The healthcare segment is anticipated to expand at a CAGR of 13.6% from 2022 to 2030. Intense competition between pharmaceutical equipment firms, rising focus on improving the remote medical treatment ecosystem, and high growth in the pediatric and geriatric populations are creating a favorable environment for enterprise software in the healthcare sector

• Asia Pacific is expected to register a CAGR of 13.4% from 2022 to 2030 owing to the significant penetration by global market players, remarkable technological advancements in the software industry, and emerging startups in various countries such as India, Singapore, Australia, Japan, and Thailand

Enterprise Software Market Segmentation

Access Press Release@ https://www.grandviewresearch.com/press-release/global-enterprise-software-market

Grand View Research has segmented the global enterprise software market based on software, deployment, enterprise size, end-use, and region:

Enterprise Software Outlook (Revenue, USD Billion, 2017 - 2030)

• Enterprise Resource Planning (ERP) Software

• Business Intelligence Software

• Content Management Software

• Supply Chain Management Software

• Customer Relationship Management Software

• Others (Marketing, Human Resource Management, Payment Processing)

Enterprise Software Deployment Outlook (Revenue, USD Billion, 2017 - 2030)

• On-premise

• Cloud

Enterprise Software Enterprise Size Outlook (Revenue, USD Billion, 2017 - 2030)

• Large Enterprise

• Small & Medium Enterprise

Enterprise Software End-use Outlook (Revenue, USD Billion, 2017 - 2030)

• BFSI

• Retail

• Healthcare

• IT & Telecom

• Government & Education

• Manufacturing

• Others (Transportation, Hospitality, Automotive)

Enterprise Software Regional Outlook (Revenue, USD Billion, 2017 - 2030)

• North America

  • U.S.

  • Canada

• Europe

  • Germany

  • U.K.

• Asia Pacific

  • China

  • India

  • Japan

• Latin America

  • Brazil

• MEA

List of Key Players of Enterprise Software Market

• Broadcom Inc. (CA Technologies, Inc.)

• Epicor Software Corporation

• Hewlett Packard Enterprise

• IBM Corporation

• Microsoft Corporation

• Oracle Corporation

• Salesforce.com, Inc.

• SAP SE

• SYSPRO

• Zoho Corporation Pvt. Ltd.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Colombia Hydrogen Generation Market Industry Analysis , Opportunity Assessment And Forecast Till 2030: Grand View Research Inc.

 

Colombia Hydrogen Generation Market Growth & Trends

The Colombia hydrogen generation market size is expected to reach USD 766.97 million by 2030, according to a new report by Grand View Research, Inc. The market is anticipated to expand at a CAGR of 10.6% from 2022 to 2030. The growth can be attributed to the rising demand for cleaner fuel and increasing governmental regulations for the desulphurization of petroleum products. Hydrogen is an effective energy carrier, which is expected to contribute significantly to its further penetration into newer markets. Colombia’s electricity demand is anticipated to witness an increase of nearly two-thirds of the current demand over the forecast period. Focus on projects related to distributed power & utility is anticipated to bolster the demand for hydrogen generation in the country.

The steam methane reforming segment was dominant in 2021 with a revenue share of 95.21% and is expected to continue leading over the forecast period. Steam methane reforming is a method for producing hydrogen, along with other gases including carbon monoxide and carbon dioxide. The steam methane reforming process is a mature and advanced technology in hydrogen generation. The growing demand for hydrogen generation across Colombia is a crucial driving factor for steam methane reformers technology, as steam methane reforming is the most economical method for hydrogen generation.

Based on application, the ammonia production segment led the market in 2021 with a share of more than 50.0%. The ammonia segment will keep its lead during the forecast period. The future growth of the hydrogen generation industry is anticipated to have steady growth as application cases for hydrogen increase. For instance, the development of a renewable ammonia project near the city of Barranquilla, on Colombia's Caribbean coast, has been agreed to by local power company Alumbrado Público Barranquilla (APBAQ) and Colombian fertilizer manufacturer Monómeros. A 350 MW offshore wind farm supported by Copenhagen Infrastructure Partners will power the manufacturing of ammonia and is anticipated to start producing power in 2026. The Colombian government unveiled an ambitious offshore wind energy program in March. The Caribbean coast holds the majority of the 50 GW potential.

Based on systems, the captive generation segment led the market in 2021. Captive generation of hydrogen is defined as on-site generation that abolishes several problems linked to the conveyance and distribution of hydrogen, and therefore the market is expected to grow substantially. Captive hydrogen production is the most commonly used supply route in Colombia and neighboring countries and the region is engaged with small volumes of merchant hydrogen production. The captive generation segment is expected to keep its lead during the forecast period.

Growing investments in smart “energy-saving” residential and commercial buildings are expected to provide an impetus toward the adoption of hydrogen for energy generation. Hydrogen is a financially viable option to investors as they also comply with federal and environmental regulations, catering to the ever-increasing demand for energy. Factors including shifting trends toward cleaner energy and favorable government regulations are contributing to the development of the market for hydrogen generation in Colombia.

Request a free sample copy or view report summary: Colombia Hydrogen Generation Market Report

Colombia Hydrogen Generation Market Report Highlights

• In terms of revenue, the steam methane reforming segment accounted for a prominent share in 2021 and is further expected to witness steady growth over the forecast period

• The ammonia production segment accounted for a leading share of more than 50.0% in terms of revenue in 2021

• Various strategic initiatives were recorded over the past few years to boost the growth of the market. For instance, The Colombian government has released a Hydrogen Roadmap that lays out the next 30 years (until 2050) for the research, generation, and use of hydrogen as a cleaner energy source and supports Colombia's move toward clean energy

• The Inter-American Development Bank (IDB) provided funding for the development of the regulatory sandbox of this plan, which was created with the assistance of the consulting firm i-deals. The roadmap aims to give Colombia the resources it needs to benefit from the wind and solar energy projects it has been creating, due to a strong regulatory environment that includes significant tax advantages

Colombia Hydrogen Generation Market Segmentation

Access Press Release@ https://www.grandviewresearch.com/press-release/colombia-hydrogen-generation-market-analysis

Grand View Research has segmented the Colombia hydrogen generation market based on technology, application, and system:

Colombia Hydrogen Generation Technology Outlook (Volume, Kilo Tons; Revenue, USD Million, 2019 - 2030)

• Steam Methane Reforming

• Coal Gasification

• Others

Colombia Hydrogen Generation Application Outlook (Volume, Kilo Tons; Revenue, USD Million, 2019 - 2030)

• Methanol production

• Ammonia Production

• Petroleum Refining

• Transportation

• Power Generation

• Others

Hydrogen Generation Systems Outlook (Volume, Kilo Tons; Revenue, USD Million, 2019 - 2030)

• Captive

• Merchant

List of Key Players in the Colombia Hydrogen Generation Market

• Linde plc

• Air Products and Chemicals, Inc

• Air Liquide

• Messer SE & Co. KGaA

• SOL SpA

• Claind srl

• HYGEAR

• Siemens Energy

• Engie

• Cummins Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Biopharma Plastics Market Size Projected to Rise Lucratively during 2022 to 2030: Grand View Research Inc.

 

Biopharma Plastics Market Growth & Trends

The global biopharma plastics market size is expected to reach USD 11.29 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 11.2% from 2022 to 2030. The growing awareness about lightweight materials used in the healthcare industry in various applications such as containers, valves, and clamps is expected to drive the demand for silicones. Superior characteristics of the biopharma plastic polymers make them highly compatible with rubber, adhesives, metals, and coatings, thus increasing their preference over other products. Increasing production of biopharma plastic products is the key factor behind the growth of this market.

The revision of the regulatory framework associated with the biopharma industry is expected to increase the safety, efficacy, and performance standards of biopharma plastic-based medical products. As a result, the demand for superior-quality biopharma plastics is expected to grow in Europe in the coming years. The market in the region is highly regulated, with stringent norms enforced for the production of biopharma plastics by the World Health Organization.

The growing demand for biopharma plastics to manufacture various medical equipment, such as drug delivery systems, beakers, test tubes, and containers for laboratory ware, IV, and dialysis fluid is expected to positively impact the growth of the market over the forecast period. The growing biopharma/medical industry coupled with the increasing demand for a hygienic and clean environment at healthcare facilities is expected to have a positive impact on the market growth over the forecast period.

The high demand for advanced healthcare services owing to the availability of well-developed healthcare infrastructure, increasing incidences of cardiovascular diseases, and rising aging population are anticipated to drive the demand for biopharma medical devices, which, in turn, is expected to drive polyethylene terephthalate demand in biopharma applications.

Request a free sample copy or view report summary: Biopharma Plastics Market Report

Biopharma Plastics Market Report Highlights

• In terms of revenue, the polyvinyl chloride polymer type segment accounted for a prominent share in 2021 and is expected to witness prominent growth over the forecast period

• The syringes application segment dominated the market and accounted for more than 20.0% share of the overall revenue in 2021. The increased demand for advanced healthcare services owing to surging incidences of cardiovascular diseases, orthopedic disorders, and endovascular diseases and expanding geriatric global population base is anticipated to drive the consumption of syringes in the market

• As of 2021, Asia Pacific accounted for the largest share of more than 30.0% in terms of revenue. The presence of a well-established manufacturing base and increased healthcare expenditure in China, Japan, and India are anticipated to provide further impetus to the regional market growth

• Major players are continuously working on developing their production plants owing to the increased usage of biopharma plastics in the healthcare industry. For instance, in April 2022, Iktos and Teijin Limited co-developed a new technology for small molecule drug discovery. Under this agreement, Iktos and Teijin Pharma will collaborate to develop new AI technology with the goal of enhancing and speeding up the drug design process

Access Press Release@ https://www.grandviewresearch.com/press-release/global-biopharma-plastics-market

Biopharma Plastics Market Segmentation

Grand View Research has segmented the global biopharma plastics market based on polymer type, application, and region:

Biopharma Plastics Polymer Type Outlook (Volume, Kilotons; Revenue, USD Million, 2019 - 2030)

• Polyethylene (PE)

• Polypropylene (PP)

• Acrylonitrile Butadiene Styrene (ABS)

• Polyethylene Terephthalate (PET)

• Polyvinyl Chloride (PVC)

• Polytetrafluoroethylene (PTFE)

• Other

Biopharma Plastics Application Outlook (Volume, Kilotons; Revenue, USD Million, 2019 - 2030)

• Protective Wear

• Containers

• Bioreactor Bags

• Syringes

• Depth Filters

• Disposable Medical Connectors

• Others

Biopharma Plastics Regional Outlook (Volume, Kilotons; Revenue, USD Million, 2019 - 2030)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • Germany

  • U.K.

  • France

  • Italy

• Asia Pacific

  • China

  • Japan

  • India

• Central & South America

  • Brazil

  • Argentina

• Middle East & Africa

  • GCC Countries

  • SouthAfrica

List of Key Players of Biopharma Plastics Market

• BASF SE

• LyondellBasell Industries Holdings B.V.

• SABIC

• LG Chem

• Toray Industries, Inc.

• Solvay

• Dow, Inc.

• DuPont de Nemours, Inc.

• Saint-Gobain Performance Plastics

• Tekni-Plex

• Chevron Phillips Chemical Co., LLC

• Exxon Mobil Corporation

• Formosa Plastics Corporation

• Covestro AG

• TEIJIN LIMITED

• Mitsui & Co. Plastics Ltd.

• INEOS Group

• CHIMEI

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Global Demand for Saliva Collection And Diagnostics Market to Incur Considerable Upsurge During 2022– 2030: Grand View Research Inc.

 

Saliva Collection And Diagnostics Market Growth & Trends

The global saliva collection and diagnostics market size is expected to reach USD 1.7 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to register a CAGR of 8.4% over the forecast period owing to the increasing prevalence of communicable and non-communicable diseases along with the increasing preference for non-invasive methods for disease diagnosis. Moreover, the growing need to diagnose COVID-19-infected symptomatic and asymptomatic patients have created significant opportunities for the market. In August 2022, a research study published in PLOS ONE stated that oral fluid samples could be used for various diagnostic assays, such as COVID-19, due to its storage and ease of sample collection. Moreover, researchers have also stated that even if the salivary samples were stored for more than 28 days, it would remain reliable and useful.

Furthermore, the global burden of cancer and related deaths rose in 2020, majorly because of the increasing aging population and socioeconomic development. In April 2020, an article published in the American Society of clinical oncology stated that more than 50% of cancers globally are diagnosed in people aged 65 and older. Therefore, the saliva-based test is considered to be the best non-invasive procedure to detect cancer. In August 2022, OrisDX announced of developing a saliva-based non-invasive molecular test to diagnose and detect oral cancer at an early stage which would help in improving patient outcomes.

There has been significant growth in the adoption of saliva samples for both clinical and research applications as it offers non-invasive sampling, easy, simple collection, and higher patient compliance, among others. Several advancements and developments are happening in saliva specimens which would advance the proteomics field. For instance, in September 2022, an article published in India Today stated that researchers from IIT Roorkee identified salivary proteins which could help in predicting metastatic triple-negative breast cancer.

Key players operating in the market are taking several initiatives such as entering into strategic alliances and launching new products which are contributing to the overall growth. For instance, in January 2021, OraSure Technologies, Inc. announced that its saliva collection device, OMNIgene·ORAL, has been selected by Chronomics Limited for the SARS CoV-2 PCR test. Similarly, in August 2020, Fluidigm Corporation announced receiving FDA authorization for its saliva-based test, Advanta Dx SARS-CoV-2 RT-PCR assay. This test would help to detect the presence of coronavirus in the sample.

Request a free sample copy or view report summary: Saliva Collection And Diagnostics Market Report

Saliva Collection And Diagnostics Market Report Highlights

• The growth of the overall saliva collection and diagnostics market is attributed to the increasing prevalence of infectious diseases along with the growing demand for non-invasive methods for disease detection

• By site of collection, the submandibular/sublingual gland collection segment dominated the market in 2021, owing to the increasing cases of sialoliths among the young population

• By application, the disease diagnostics segment dominated the market in 2021 owing to the increasing aging population globally coupled with increasing cases of diseases such as cancer, cardiovascular diseases, and others

• By end use, the diagnostic laboratories segment captured the highest market share in 2021, owing to the growing number of diagnostic labs along with the introduction of advanced technology which could help in the early detection of diseases

• By region, North America dominated the market in 2021 owing to the presence of several market players along with increasing support from the government to boost the demand in the region

Access Press Release@ https://www.grandviewresearch.com/press-release/global-saliva-collection-diagnostics-market

Saliva Collection And Diagnostics Market Segmentation

Grand View Research has segmented the global saliva collection and diagnostics market on the basis of site of collection, application, end-use, and region:

Saliva Collection And Diagnostics Site of Collection Outlook (Revenue, USD Million, 2018 - 2030)

• Parotid Gland Collection

• Submandibular/Sublingual Gland Collection

• Others

Saliva Collection And Diagnostics Application Outlook (Revenue, USD Million, 2018 - 2030)

• Disease Diagnostics

• Forensic Applications

• Research

Saliva Collection And Diagnostics End-use Outlook (Revenue, USD Million, 2018 - 2030)

• Dentistry

• Diagnostic Laboratories

• Pharmaceutical & Biotechnology Companies

• Research Institutes

Saliva Collection And Diagnostics Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

  • U.S.

  • Canada

• Europe

  • U.K.

  • Germany

  • France

  • Spain

  • Italy

• Asia Pacific

  • Japan

  • China

  • India

  • South Korea

  • Australia

• Latin America

  • Brazil

  • Mexico

  • Argentina

• Middle East & Africa

  • South Africa

  • Saudi Arabia

  • UAE

List Of Key Players Of Saliva Collection And Diagnostics Market

• Thermo Fisher Scientific, Inc.

• Neogen Corporation

• Abbott

• Sarstedt AG & Co.KG

• Autogen, Inc.

• Oasis Diagnostics

• Porex

• Salimetrics, LLC

• Takara Bio, Inc.

• Arcis Bio

• Orasure Technologies

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Global Parkinson’s Disease Treatment Market to Register Stable Expansion During 2022 – 2030: Grand View Research Inc.

 

Parkinson’s Disease Treatment Market Growth & Trends

The global Parkinson’s disease treatment market size is expected to reach USD 11.98 billion by 2030, according to a new report by Grand View Research, Inc., growing at a CAGR of 12.1% from 2022 to 2030. This can be attributed to the rising investment in the research and development of novel treatments for PD. In August 2021, the Parkinson’s Foundation announced an investment of USD 43 million as a research grant to 29 research projects having the goal of developing novel treatments and therapies for PD. In addition, in May 2021, the Parkinson’s Foundation announced an investment of USD 10 million for research, care, and educational programs related to Parkinson’s Disease (PD). This investment may aid in providing awareness and genetic testing free of cost to people suffering from PD.

Such investment initiatives are expected to boost industry growth. In the last ten years, there have been significant R&D activities in the PD therapy sector, leading to the development of innovative drug-delivery methods. Due to fewer side effects, these cutting-edge drug delivery systems outperform the existing ones. In addition, the rate of prescription for these techniques has increased due to a rise in patient compliance, which is fueling the expansion of the industry. Moreover, key pharmaceutical companies are undertaking initiatives, such as collaborations and partnerships, for the development, manufacturing & commercialization of products to meet the rising demand for disease treatment in the international market.

For instance, in November 2021, STADA Arzneimittel and Bioglan formed a partnership to expand the production capacity of the medicine Lecigon (levodopa/carbidopa/entacapone) used to treat patients with PD. Thus, increasing demand for medicines that are used to treat patients with PD is anticipated to drive industry growth. However, the limited availability of neurologists leads to issues, such as longer waiting times for patients and difficulty in hiring new neurosurgeons in hospitals. In addition, some of the currently practicing neurologists avoid accepting new Medicaid patients, which creates difficulty for patients who want to switch to another doctor. According to the American Academy of Neurology (AAN) report, around 19% shortage of neurologists is projected by 2025.

Request a free sample copy or view report summary: Parkinson’s Disease Treatment Market Report

Parkinson’s Disease Treatment Market Report Highlights

• By drug class, the Carbidopa-Levodopa segment held the largest revenue share in 2021 due to the high prevalence of PD and easy drug availability for the disease treatment

• The retail pharmacy distribution channel segment dominated the global industry in 2021

• This is due to the easy availability of PD drugs in well-established retail pharmacy chains including Walgreens and Walmart

• Asia Pacific is expected to be the fastest-growing region during the forecast period due to the entry of new products into the market

• In June 2020, Ono Pharmaceutical Co., Ltd. received manufacturing and marketing approval for Ongentys to treat patients with PD in Japan

Access Press Release@ https://www.grandviewresearch.com/press-release/global-parkinsons-disease-treatment-market

Parkinson’s Disease Treatment Market Segmentation

Grand View Research has segmented the global Parkinson’s disease treatment market on the basis of drug class, distribution channel, and region:

Parkinson’s Disease Treatment Drug Class Outlook (Revenue, USD Million, 2018 - 2030)

• Carbidopa-levodopa

• Dopamine Agonists

• MAO-B Inhibitors

• COMT Inhibitors

• Anticholinergics

• Others

Parkinson’s Disease Treatment Distribution Channel Outlook (Revenue, USD Million, 2018 - 2030)

• Hospital Pharmacy

• Retail Pharmacy

• Online Pharmacy

Parkinson’s Disease Treatment Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

  • U.S.

  • Canada

• Europe

  • Germany

  • U.K.

  • France

  • Italy

  • Spain

• Asia Pacific

  • Japan

  • China

  • India

  • Australia

  • South Korea

• Latin America

  • Brazil

  • Mexico

  • Argentina

• Middle East and Africa (MEA)

  • South Africa

  • Saudi Arabia

  • UAE

List of Key Players in the Parkinson’s Disease Treatment Market

• Cerevel Therapeutics

• Novartis AG

• Teva Pharmaceutical Industries Ltd.

• Merck & Co., Inc.

• GlaxoSmithKline plc. (GSK)

• AbbVie, Inc.

• H. Lundbeck A/S

• Amneal Pharmaceuticals LLC

• Supernus Pharmaceuticals, Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.